Revenue Boomed, Profit Crushed — the Philippines Ethanol Plant's ₹83 Crore Drag

ISGEC's Q1 results embody a paradox. Consolidated revenue surged 47.7% to ₹1,980 Cr. Standalone revenue jumped 51% to ₹1,585 Cr. The order book stands at ₹7,727 Cr. Management raised full-year guidance from 8–9% to 10–12% growth. A ₹502 Cr capex program was approved to add ₹1,200 Cr in annual revenue capacity by 2028–29. By every operational measure, this was a strong quarter. Yet consolidated PAT collapsed 70.2% to ₹17.5 Cr from ₹59 Cr a year ago. That gap — near-doubling of revenue, near-halving of profit — is the story of the quarter.

The culprit is not the core business. It is Cavite Biofuel, the Philippines ethanol plant, which lost ₹83 Cr in Q1 alone. The plant, running at 65–70% capacity, incurred ₹37 Cr in depreciation, ₹20 Cr in interest, ₹10 Cr in forex losses, and ₹16 Cr in fixed costs. This subsidiary was reclassified from held-for-sale to continuing operations in March 2026, so its losses now flow into consolidated results. Management expects losses to decline materially in Q2 (depreciation + interest only, no EBITDA loss) and the plant to approach breakeven on EBITDA by FY28 at 90% utilization. But for the next four quarters, this asset will drain ₹80–95 Cr per year, suppressing consolidated profitability despite core operating strength.

The market's verdict on Q1 came fast and unforgiving. The stock dropped 7.52% on day 1 (the announcement day), and by day 3 the decline had widened to 9.27%. This was not a pop-and-fade story; the market rejected the print. Today the stock sits at ₹782.2, a decline of 29.78% from its all-time high of ₹1,113.9. It is trading below its SMA20 (₹815.91), SMA50 (₹873.6), and SMA200 (₹891.56) — all major moving averages are downtrending. RSI of 32 suggests neutral-to-oversold territory. Volume is increasing, signaling capitulation or sustained selling pressure.

The ownership structure has been stable and unconcerned. FII holding at 3.76% (down 9 bps from Q4), DII at 10.23% (down 8 bps). Promoters at 62.43%, unchanged. The lack of aggressive insider buying into this 30% drawdown is notable — management is holding steady but not signaling conviction through action.

What the market is pricing in: The street has correctly identified the profit problem and is discounting the stock for near-term earnings suppression. The 29.78% drawdown from ATH and the trade below all moving averages reflect fear that the ethanol plant is a value-destroying drag, the capex opportunity is oversold, and FY27 guidance is too optimistic given margin compression. The widening day-1 to day-3 move (-7.52% to -9.27%) suggests the selling is accelerating, not stabilizing. This is a 'sell the rally' regime.

Standalone EBIT margin trend. Q1 achieved 12% in manufacturing and 5.25% in projects. FY27 guidance is 12–13% manufacturing and 5–6% projects. If Q2–Q3 margins decline below 12% manufacturing or below 5% projects, it signals that geopolitical cost pressures, interest burden, or order quality is degrading. Margin hold = guidance intact = capex opportunity credible. Margin slip = warning flag = reduce exposure until clarity.